Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Gastrointestinal Endoscopy
|
November 5, 2021
Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium
Tamas A Gonda, James Farrell, Michael Wallace, et al.
Clinical Chemistry
|
October 8, 2013
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125
Ioannis Prassas, Davor Brinc, Sofia Farkona, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 13, 2006
Improved fecal DNA test for colorectal cancer screening
Steven H Itzkowitz, Lina Jandorf, Randall Brand, et al.
Cancer Research
|
December 3, 2005
Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer
Randal Orchekowski, Darren Hamelinck, Lin Li, et al.
Journal of Genetic Counseling
|
July 12, 2019
The impact of genetic counseling on patient engagement in a specialty cancer clinic
Anna L Zakas, Claire Leifeste, Beth Dudley, et al.
The American Journal of Gastroenterology
|
September 2, 2008
A simplified, noninvasive stool DNA test for colorectal cancer detection
Steven Itzkowitz, Randall Brand, Lina Jandorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2018
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
Elena M Stoffel, Shannon E McKernin, Randall Brand, et al.
Plos One
|
February 6, 2013
Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer
Sukhwinder Kaur, Subhankar Chakraborty, Michael J Baine, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 30, 2013
Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012
Michael R Rickels, Melena Bellin, Frederico G S Toledo, et al.
Molecular & Cellular Proteomics : MCP
|
June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues
Hari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Gastrointestinal Endoscopy
|
November 5, 2021
Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium
Tamas A Gonda, James Farrell, Michael Wallace, et al.
Clinical Chemistry
|
October 8, 2013
False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125
Ioannis Prassas, Davor Brinc, Sofia Farkona, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 13, 2006
Improved fecal DNA test for colorectal cancer screening
Steven H Itzkowitz, Lina Jandorf, Randall Brand, et al.
Cancer Research
|
December 3, 2005
Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer
Randal Orchekowski, Darren Hamelinck, Lin Li, et al.
Journal of Genetic Counseling
|
July 12, 2019
The impact of genetic counseling on patient engagement in a specialty cancer clinic
Anna L Zakas, Claire Leifeste, Beth Dudley, et al.
The American Journal of Gastroenterology
|
September 2, 2008
A simplified, noninvasive stool DNA test for colorectal cancer detection
Steven Itzkowitz, Randall Brand, Lina Jandorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2018
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
Elena M Stoffel, Shannon E McKernin, Randall Brand, et al.
Plos One
|
February 6, 2013
Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer
Sukhwinder Kaur, Subhankar Chakraborty, Michael J Baine, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 30, 2013
Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012
Michael R Rickels, Melena Bellin, Frederico G S Toledo, et al.
Molecular & Cellular Proteomics : MCP
|
June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues
Hari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.
Page
of 7